We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Promega Opposes High Court Review Of Invalidity Ruling In Amplification Patents

(September 11, 2015, 11:16 AM EDT) -- WASHINGTON, D.C. — Promega Corp. asserts in an opposition brief filed Aug 26 that the U.S. Supreme Court should not review a lower court’s interpretation and application of an infringement statute in a ruling that reversed an order vacating Promega’s $52 million victory in a patent and licensing dispute over gene-testing technology (Life Technologies Corp., et al. v. Promega Corp., No. 14-1538, U.S. Sup.).

(Opposition brief available. Document #78-150921-003B.)

Promega asserted U.S. patent Nos. 5,843,660, 6,221,598, 6,479,235 and 7,008,771 (the Promega patents, collectively), as well as...
To view the full article, register now.